Summary
Background
Analgesia and sedation are key items in intensive care. Recently published S3 guidelines specifically address treatment of patients with elevated intracranial pressure.
Methods
The Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine carried out an online survey of neurointensive care units in Austria in order to evaluate the current state of practice in the areas of analgosedation and delirium management in this high-risk patient group.
Results
The response rate was 88%. Induction of anesthesia in patients with elevated intracranial pressure is carried out with propofol/fentanyl/rocuronium in >80% of the intensive care units (ICU), 60% use midazolam, 33.3% use esketamine, 13.3% use barbiturates and 6.7% use etomidate. For maintenance of analgosedation up to 72 h, propofol is used by 80% of the ICUs, followed by remifentanil (46.7%), sufentanil (40%) and fentanyl (6.7%). For long-term sedation, 86.7% of ICUs use midazolam, 73.3% sufentanil and 73.3% esketamine. For sedation periods longer than 7 days, 21.4% of ICUs use propofol. Reasons for discontinuing propofol are signs of rhabdomyolysis (92.9%), green urine, elevated liver enzymes (71.4% each) and elevated triglycerides (57.1%). Muscle relaxants are only used during invasive procedures. Inducing a barbiturate coma is rated as a last resort by 53.3% of respondents. The monitoring methods used are bispectral index (BIS™, 61.5% of ICUs), somatosensory-evoked potentials (SSEP, 53.8%), processed electroencephalography (EEG, 38.5%), intraparenchymal partial pressure of oxygen (pO2, 38.5%) and microdialysis (23.1%). Sedation and analgesia are scored using the Richmond agitation and sedation score (RASS, 86.7%), sedation agitation scale (SAS, 6.7%) or numeric rating scale (NRS, 50%) and behavioral pain scale (BPS, 42.9%), visual analogue scale (VAS), critical care pain observation tool (CCPOT, each 14.3%) and verbal rating scale (VRS, 7.1%). Delirium monitoring is done using the confusion assessment method for intensive care units (CAM-ICU, 46.2%) and intensive care delirium screening checklist (ICDSC, 7.7%). Of the ICUs 46.2% do not carry out delirium monitoring.
Conclusion
We found good general compliance with the recommendations of the current S3 guidelines. Room for improvement exists in monitoring and the use of scores to detect delirium.
Similar content being viewed by others
References
AWMF. S3-Leitlinie Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie 2015) AWMF-Registernummer: 001/012 2015. http://www.awmf.org/uploads/tx_szleitlinien/001-012l_S3_Analgesie_Sedierung_Delirmanagement_Intensivmedizin_2015-08_01.pdf. Accessed 7 Jan 2017.
Oddo M, Crippa IA, Mehta S, Menon D, Payen JF, Taccone FS, Citerio G. Optimizing sedation in patients with acute brain injury. Crit Care. 2016;20:128.
Haddad SH, Arabi YM. Critical care management of severe traumatic brain injury in adults. Scand J Trauma Resusc Emerg Med. 2012;20:12.
Herzer G, Trimmel H. Neuroanästhesie. Grundlagen der perioperativen Betreuung. Anaesthesist. 2010;59:371–84.
Flower O, Hellings S. Sedation in traumatic brain injury. Emerg Med Int. 2012; doi:10.1155/2012/637171.
Hertle DN, Dreier JP, Woitzik J, et al. Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury. Brain. 2012;135:2390–8.
Bouzat P, Sala N, Payen JF, et al. Beyond intracranial pressure: optimization of cerebral blood flow, oxygen, and substrate delivery after traumatic brain injury. Ann Intensive Care. 2013;3(1):23.
Herzer G, Illievich U, Voelckel WG, Trimmel H. Current practice in neurocritical care of patients with subarachnoid haemorrhage and severe traumatic brain injury: Results of the Austrian Neurosurvey Study. Wien Klin Wochenschr. 2016;128(17–18):649–57.
Gagliese L, et al. The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients. Pain. 2005;117(3):412–20.
Payen J‑F, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001;29(12):2258–63.
Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38(6):633–8.
Gélinas C, Fillion L, Puntillo KA, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care. 2006;15(4):420–7.
Herr KA, Spratt K, Mobily PR, Richardson G. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004;20(4):207–19.
Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983–91.
Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27(7):1325–9.
Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–10.
Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med. 2001;27(5):859–64.
Diringer MN, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211–40.
Trauma Foundation B. Guidelines for the Management of Severe Traumatic Brain Injury. 4th Edition 2016. https://braintrauma.org/uploads/03/12/Guidelines_for_Management_of_Severe_TBI_4th_Edition.pdf. Accessed 8 Jan 2017.
AWMF. Leitlinie “Polytrauma/Schwerverletzten-Behandlung”. Registernummer 012-019, Stand vom 01.07.2016 2016. http://www.awmf.org/leitlinien/detail/ll/012-019.html. Accessed 8 Jan 2017.
Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008;34:714–9.
Schmittner MD, Vajkoczy SL, Horn P, et al. Effects of fentanyl and S(+)-ketamine on cerebral hemodynamics, gastrointestinal motility, and need of vasopressors in patients with intracranial pathologies: a pilot study. J Neurosurg Anesthesiol. 2007;19(4):257–62.
Chang LC, Raty SR, Ortiz J, et al. The emerging use of ketamine for anesthesia and sedation in traumatic brain injuries. CNS Neurosci Ther. 2013;19(6):390–5.
Sakowitz OW, Kiening KL, Krajewski KL, et al. Preliminary evidence that ketamine inhibits spreading depolarizations in acute human brain injury. Stroke. 2009;40(8):e519–e22.
Karabinis A, Mandragos K, Stergiopoulos S, et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Crit Care. 2004;8(4):R268–80.
Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol. 2009;75:339–44.
Tan CK, Lai CC. Cheng KC Propofol-related green urine. Kidney Int. 2008;74:978. doi:10.1038/ki.2008.139.
Shioya N, Ishibe Y, Shibata S. Green urine discoloration due to propofol infusion: a case report. Case Rep Emerg Med. 2011;2011:242514.
Rawal G, Yadav S. Green urine due to propofol: a case report with review of literature. J Clin Diagn Res. 2015; doi:10.7860/jcdr/2015/15681.6706.
Majdan M, Mauritz W, Wilbacher I, et al. Barbiturates use and its effects in patients with severe traumatic brain injury in five European countries. J Neurotrauma. 2013;30(1):23–9.
Sharshar T, Citerio G, Andrews PJ, et al. Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel. Intensive Care Med. 2014;40(4):484–95.
Helbok R, Kurtz P, Schmidt MJ, et al. Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients. Crit Care. 2012;16(6):R226.
European Medicines Agency. Dexdor, Annex I – Summary of product characteristics 2016. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002268/WC500115631.pdf. Accessed 8 Jan 2017.
Martin J, Franck M, Fischer M, Spies C. Sedation and analgesia in German intensive care units: how is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive Care Med. 2006;32(8):1137–42.
Martin J, Franck M, Sigel S, Weiss M, Spies C. Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care. 2007;11(6):R124.
Kowoll CM, Dohmen C, Kahmann J, Initiative of German NeuroIntensive Trial Engagement (IGNITE), Kahmann J et al. for the Initiative of German NeuroIntensive Trial Engagement. Standards of scoring, monitoring, and parameter targeting in German neurocritical care units: a national survey. Neurocrit Care. 2014;20:176–86.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
G. Herzer, C. Mirth, U.M. Illievich, W.G. Voelckel, and H. Trimmel declare that they have no competing interests.
Appendix
Appendix
Current guidelines in neurointensive care
-
1.
Le Roux P, Menon DK, Citerio G et al. Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Intensive Care Med. 2014 Sep;40(9):1189–209
-
2.
Brain Trauma Foundation. Guidelines for the Management of Severe Traumatic Brain Injury. 4th Edition.
-
3.
https://braintrauma.org/uploads/03/12/Guidelines_for_Management_of_Severe_TBI_4th_Edition.pdf accessed 08.01.2017
-
4.
AWMF online. Schädel-Hirn-Trauma im Erwachsenenalter. Registernummer 008–001. http://www.awmf.org/leitlinien/detail/ll/008-001.html accessed 24.01.2017
-
5.
Diringer MN et al. Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference Neurocrit Care (2011) 15:211–240
-
6.
Deutsche Gesellschaft für Neurologie. Subarachnoidalblutung (SAB). AWMF-Registernummer: 030/073. http://www.dgn.org/leitlinien/2318-ll-26-2012-subarachnoidalsblutung-sab accessed 24.01.2017
-
7.
Steiner T, Juvela S, Unterberg A et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112. doi: 10.1159/000346087
-
8.
Wijdicks EF, Sheth KN, Carter BS et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Apr;45(4):1222–38. doi: 10.1161/01.str.0000441965.15164.d6.
-
9.
Hemphill JC 3rd, Greenberg SM, Anderson CS et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Jul;46(7):2032–60. doi: 10.1161/STR.0000000000000069
-
10.
Powers WJ, Derdeyn CP, Biller J et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Oct;46(10):3020–35. doi: 10.1161/STR.0000000000000074
Rights and permissions
About this article
Cite this article
Herzer, G., Mirth, C., Illievich, U.M. et al. Analgosedation of adult patients with elevated intracranial pressure. Wien Klin Wochenschr 130, 45–53 (2018). https://doi.org/10.1007/s00508-017-1228-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-017-1228-5